Market Newsdesk

PHOENIX, Nov. 12, 2020 (GLOBE NEWSWIRE) — Supporting customers and protecting the health and safety of employees, contractors and customers has remained EPCOR’s focus since the COVID-19 pandemic began.

To help communities recover from the impacts of COVID-19, EPCOR created a one-time COVID-19 Community Impact Fund focused on providing financial support to locally based non-profits providing essential services. Today, EPCOR announced $27,000 in support for six community-based organizations that serve the company’s service areas in New Mexico and Texas.

• Food Bank of Eastern New Mexico – Clovis, NM
• Bethel Community Storehouse – Edgewood, NM
• Edgewood Area Chamber of Commerce – Edgewood, NM
• United Way of Eastern New Mexico – Clovis, NM
• San Antonio Food Bank – San Antonio, Texas
• Montgomery County Food Bank – Conroe, Texas

“Supporting our communities is at the heart of what we do and that is, perhaps, more vital than ever before,” said Joe Gysel, President of EPCOR USA. “Eight months into this pandemic, COVID-19 continues to have a far-reaching impact on the communities we serve. As we head into the holiday season, the need for food and essential care will become more important than ever. We are proud to be able to support local organizations focused on ensuring families continue to have the support they need.”

These donations are the latest step taken by the company to support customers affected by COVID-19. Since March 2020, EPCOR has suspended disconnections and offered bill payment support for customers whose employment has been disrupted or who have been hospitalized due to COVID-19.

“The COVID-19 pandemic has greatly affected our community. As part of our disaster response, distribution to people seeking food assistance has increased 35%,” said Kristine Marlow, President and CEO of the Montgomery County Food Bank. “We are serving families, children and seniors who may have never before asked for help. They are our neighbors, and they need our help. We are so thankful for EPCOR’s generosity to help feed our neighbors in need.”

“These are very tough times for families, with so many facing eviction and utility shut off,” noted Erinn Burch, Executive Director of the United Way of Eastern New Mexico. “EPCOR’s donation will allow us to keep families SAFE in their homes as we go into the winter months. United Way of Eastern New Mexico is so grateful for this chance to offer help and hope during the pandemic – it is only possible through gifts like this one from EPCOR.”

“Thousands of families are unsure if they will be able to put food on the table this holiday season. While the need is great, our community continues to step up and give the gift of food, time, money and voice,” said Eric Cooper, CEO & President of the San Antonio Food Bank. “The donation from EPCOR will ensure 42,000 meals are distributed throughout our 16-county service area. We are humbled and grateful to have them as our partner.”

Visit epcor.com for more on EPCOR’s COVID-19 response.

For further information, please contact:

Rebecca Stenholm
Director, Public & Government Affairs
EPCOR USA
O 623.445.2424 | C 602.390.5662 | [email protected]

About EPCOR USA

Headquartered in Phoenix, Arizona, EPCOR USA’s wholly owned subsidiaries build, own and operate water and wastewater and natural gas facilities and infrastructure in the southwestern United States. EPCOR USA provides water, wastewater, wholesale water and natural gas services to approximately 670,000 customers across 39 communities and 15 counties in Arizona, New Mexico and Texas.

About EPCOR Utilities Inc.

EPCOR, through its wholly owned subsidiaries, builds, owns and operates electrical, natural gas and water transmission and distribution networks, water and wastewater treatment facilities, sanitary and stormwater systems, and infrastructure in Canada and the United States. The Company also provides electricity, natural gas and water products and services to residential and commercial customers. EPCOR, headquartered in Edmonton, is an Alberta Top 75 employer.

 

FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Craig-Hallum and Canaccord Genuity investor conferences in November. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be available to host one-on-one meetings with investors who are registered to attend the conferences.

• Craig
  –
  Hallum
  11
  
  ^th
  
  Annual Alpha Select Conference
  Date: Tuesday, November 17^th

• Canaccord Genuity Virtual MedTech & Diagnostics Forum
  Date: Thursday, November 19^th

For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations firm, JCIR, at [email protected].

About Misonix, Inc.

Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company’s wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company’s web site at www.misonix.com.

Contact:
Joe Dwyer	Norberto Aja, Jennifer Neuman
Chief Financial Officer	JCIR
Misonix, Inc.	212-835-8500 or [email protected]
631-927-9113

LOS ANGELES, Nov. 12, 2020 (GLOBE NEWSWIRE) — ProSearch, a leading provider of comprehensive discovery and compliance solutions to corporate legal departments and law firms, announces the expansion of its solutions advisory team which supports ProSearch client teams with advanced training and expertise, providing an added layer of assistance to ProSearch Enterprise clients. The additions to the team are a direct result of the growth in both the number and scope of ProSearch Enterprise client installations this year.

ProSearch reimagines the conventional approach to solution design and service delivery, helping clients take control of their discovery processes by staying focused on legal and strategic issues while reducing risk and costs. The company’s Enterprise solution aligns ProSearch with clients in a way that traditional customer/vendor relationships cannot, with its team becoming an extension of the client’s, listening and collaborating on solutions that maximize investments and improve outcomes.

ProSearch client service teams consist of discovery experts, analysts and data scientists who leverage industry-leading tools and technologies, including ProSearch proprietary solutions and tailored workflows, to provide innovative, full-service discovery solutions. As part of that client-centric service model, the expanded solutions advisory team consists of senior project managers, lawyers and other discovery experts who work closely with clients to provide an added layer of support with ongoing training, use case demonstrations and expert consultation on both internal and external tools and processes.

“Rapid technology advances in both data and legal discovery require that our client service teams evolve as well, so we are able to help our clients stay ahead of the curve and guide them to successful outcomes,” shares Matt Davidson, ProSearch director of client services. “As subject matter experts and industry thought leaders, all of the additions to our solutions advisory team strengthen the whole with their contributions. With our recent growth, the team is already busy sharing their expertise and perspectives on AI, workstream applications, IoT, data privacy regulations and other key trends and technologies for the benefit of our clients.”

The expanded team includes industry veterans new to ProSearch as well as several recently promoted ProSearch experts. In addition to its most recent hires, the company anticipates further expansion of its solutions advisory team in the coming months to support continued growth in Enterprise client installations.

About ProSearch

ProSearch enables corporations and law firms to meet electronic discovery, fraud investigation, compliance and information governance requirements at scale with precision and ease. The ProSearch team of consultants, data scientists, linguists, project managers, attorneys and discovery specialists collaborates with clients to execute their matter strategies and ensure on-target, on-budget, on-time delivery. Learn more about solutions and careers at ProSearch by visiting Prosearch.com.

Media Contact

Vicki LaBrosse
Edge Legal Marketing
[email protected]
651-552-7753

Guilford, CT, Nov. 12, 2020 (GLOBE NEWSWIRE) — Hyperfine is initiating a global research program supported by a $1.6 million grant from the Bill & Melinda Gates Foundation to investigate whether portable magnetic resonance imaging (MRI) in low-resource countries without readily-accessible MRI technology can identify and potentially mitigate labor- and delivery-related brain damage resulting in HIE (hypoxic ischemic encephalopathy) in infants.   

HIE is caused by birth asphyxia or limited blood flow to the brain, often occurring before or during birth, and is estimated to affect about 1.5 births per 1,000 live births.ⁱ According to the World Health Organization, it is the fifth leading cause of death worldwide in children under the age of 5,ⁱⁱ with the incidence of HIE higher in countries with limited resources.ⁱⁱⁱ  The most important current treatment for HIE is therapeutic hypothermia (cooling the infant’s brain), and current guidelines recommend that this treatment commence as soon as possible after the injury and within 6 hours of birth.^iv Swoop™ portable MR imaging could enable rapid identification of HIE, providing time-critical decision-making support to deploy therapeutic hypothermia as soon as possible.

The foundation’s interest in the program, as part of its focus on Maternal, Newborn and Child Health, stems from the utility and applicability of low-field MR imaging to deliver accessible neuroimages that could identify birth asphyxia-related brain injuries and provide an opportunity for therapeutic intervention.  In addition, portable MR imaging technology could assess brain volume and detect malnutrition in the first year of life, providing an opportunity for early nutritional interventions.

The foundation’s grant will support the deployment of 20 Swoop™ devices to investigators and will fund the program for the next two years.  Ten devices will be sent to leadership sites to validate protocols for research programs and explore data outcomes, and another ten devices will be sent to lower resource settings in which birth-related brain injuries and malnutrition are persistent and access to MRI technology is limited.  The Swoop™ devices will start shipping to identified sites in 2020, and all 20 systems will be delivered by the Spring of 2021.

”The impact of maternal anaemia, malnutrition, infection and birth-related brain injury in less developed countries is very worrying,” commented the principal investigator, Professor Steve Williams from Kings College London.  “By creating unprecedented access to this pioneering technology, we will learn to assess and manage brain health for a wide range of clinical conditions. We are extremely enthusiastic about the potential impact this could have on babies and their families in the future.”

 “We are a mission in the form of a company — to make MR imaging accessible and affordable to everyone — and this research program is a perfect example of realizing that vision,” commented Dr. Khan Siddiqui, Hyperfine’s Chief Medical Officer. “We are so appreciative of the support from the foundation to help us improve the lives of mothers and children in underdeveloped countries by providing immediate and affordable access to the technology they need to improve patient outcomes.”

ABOUT MR IMAGING and the Swoop™ Portable MRI System

Magnetic Resonance Imaging (MRI) uses a magnetic field, radio waves, and a computer to produce detailed pictures of the body’s internal structures that are clearer, more detailed, and more likely in some instances to identify and accurately characterize disease than other imaging methods. However, fixed MRI systems can be inconvenient and inaccessible for providers and patients, particularly when time is critical. Transport to the MR suite demands complicated scheduling coordination, moving patients, and, often, 4- to 6-hour patient backlogs — all of which compromise the utility of MRI as a diagnostic tool in time-sensitive settings, such as intensive care units and emergency rooms. Furthermore, high capital investments, electrical power needs, and significant maintenance requirements present barriers to adoption across all populations, acutely so for developing countries and rural geographies.

Hyperfine’s Swoop™ Portable MR Imaging System is designed to address the limitations of current imaging technologies and make MRI accessible anytime, anywhere, to any patient. Swoop™ wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled by an Apple iPad^®. Images that display the internal structure of the head are captured at the patient’s bedside, with results in minutes, enabling critical decision-making capabilities across a variety of clinical settings, such as neurointensive care units, emergency departments, pediatrics, ambulatory outpatient surgery centers and more. Designed as a complementary system to traditional MRIs, new users can be trained on system operation, device navigation and device safety in about 30 minutes, helping clinicians streamline workflow. The complete Hyperfine system costs less than the annual service contract alone for most current MRI systems.

About Hyperfine Research

Hyperfine lives to make MR imaging available to everyone.  The Swoop™ Portable MR Imaging System is the result of a total rethink of MR’s potential in the healthcare landscape. What if MR imaging didn’t require a dedicated suite, extensive training or expensive upkeep? Let’s use the wonders of high-field MRI for the appropriate patients, and deploy Swoop™ at the point-of-care for everyone else.  Hyperfine received market-ready FDA clearance for its portable MR imaging for the brain and head of patients of all ages in August 2020, and has been recognized as the Best New Radiology Vendor of 2020 by Aunt Minnie and with a Best Practices Product Innovation Award from Frost & Sullivan since the product launched. Hyperfine is part of 4Catalyzer, a health technology incubator with facilities in CT, NY, CA and Taiwan. www.hyperfine.io.

 

###

---

ⁱ Kurinczuk, J. J., White-Koning, M., & Badawi, N. (2010). Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy. Early human development, 86(6), 329-338.

ⁱⁱ Hypoxic-Ischemic Encephalopathy. (2019, February 03). Retrieved March 28, 2019, from https://emedicine.medscape.com/article/973501-overview#a2

ⁱⁱⁱ Zanelli, S. A., Stanley, D. P., & Kaufman, D. A. (n.d.). What is the global prevalence of hypoxic-ischemic encephalopathy (HIE)? Retrieved March 28, 2019, from https://www.medscape.com/answers/973501-106461/what-is-the-global-prevalence-of-hypoxic-ischemic-encephalopathy-hie

^iv The Academica Medical Center Patient Safety Organization (AMC PSO) Neonatal Encephalopathy Task Force. (2016). Therapeutic Hypothermia in Neonates: Recommendations of the Neonatal Encephalopathy Task Force[Pamphlet]

 

Attachment

• swoop image for use oct 2020 png small

Chris Ward
Hyperfine
1-866-SWOOP-MR
[email protected]

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Adstra, the first Data Bureau designed to help marketers orchestrate data across all dimensions of their efforts, today announced a partnership with data sharing platform Karlsgate. The partnership will enable Adstra’s clients to securely share data using Karlsgate Identity Exchange™.

Karlsgate Identity Exchange ensures the highest level of data security and privacy compliance by using patent-pending Cryptoidentity™, single-use pseudonymized tokens, and a distributed network architecture to match two data sets without sharing or exposing Personal Data.

“The legacy infrastructure for data sharing leaves risky gaps in identity protection,” said Brian Mullin, Founder and CEO at Karlsgate. “Karlsgate Identity Exchange represents a new paradigm for securely sharing and matching data sets without transferring custody to any third party – protecting identities from disclosure, retention, persistency or reidentification.”

Through the partnership, Karlsgate’s technology becomes one of multiple ways to securely share and action on identity data through the Adstra Data Bureau. Facing a cookieless future and new privacy regulations, Adstra has struck a number of deals with next-generation data sharing platforms and technologies that provide novel means for secure data sharing.

“Cryptoidentities and the pseudonymized tokens represent one of the most promising solutions for the first-party data era,” said Andy Johnson, Chief Data Officer at Adstra Data. “Karlsgate is among a select grouping of innovative companies that have established new frameworks for secure data sharing.”

As the industry’s first Data Bureau, Adstra can ingest any form of identity (individual or household), assign a persistent ID connected to attribute data, and action against any other media or form of identity. It works independently of a brand’s choice in technology and enables brands to meet privacy regulations by linking its data back to validated individuals or customers. A Data Bureau is compatible with CDPs, DMPs, onboarders, and marketing clouds, facilitating privacy-compliant portability of critical data and intelligence between these different systems. The Karlsgate Identity Exchange offers Adstra’s clients a new secure option for data matching and orchestration.

ABOUT ADSTRA

Adstra is the new data model for the data-driven enterprise. Adstra comprises a comprehensive suite of portable data and identity solutions, offered via an all-inclusive subscription-based model that liberates brands to realize the incremental value from their data without worrying about incremental costs.

ABOUT KARLSGATE

Karlsgate is a secure data integration company providing zero-trust data sharing. Through the Karlsgate Identity Exchange and patent-pending Cryptoidentity, we empower data owners, brands, publishers, agencies and technology companies to share consumer insights freely without exposing consumer identities to the risks of disclosure, retention, persistency or re-identification.

Media Contact:

Hugh S. Moore
Broadsheet Communications for Adstra
202-471-0661
[email protected]

SANTA CLARA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Technology innovator Pliops today announced that it has received a Flash Memory Summit (FMS) 2020 ‘Best of Show Award’ in the ‘Most Innovative Flash Memory Enterprise Business Application’ category. The Pliops Storage Processor (PSP) – a hardware-enabled storage engine in a PCIe card form factor – was selected for its ability to utilize storage class memory (SCM) and QLC NVMe SSDs to accelerate and protect databases for cloud and enterprise applications. The PSP offers a very simple and effective option for lowering the total cost of ownership of public/private cloud infrastructure and on-premise data centers.

According to Jay Kramer, chairman of the awards program and president of Network Storage Advisors Inc., “The cloud data explosion and the increasing storage capacity requirements of cloud database applications are driving the need for new technology to deliver the performance and efficiencies demanded by data centers. The Pliops Storage Processor provides the ability to optimize tiered storage solutions of SCM and QLC NVMe SSDs for databases. This enables diverse application workloads and the acceleration of cloud database environments while delivering 7x more transactions per second (TPS), 5x faster queries per second (QPS), and 3x more usable storage capacity to achieve new levels of scale, speed and cost effectiveness. These impressive numbers were instrumental in Pliops winning this award.”

“The value of Pliops Storage Processor comes by exponentially increasing data center efficiency while requiring no application changes,” noted Steve Fingerhut, president and chief business officer for Pliops. “Pliops has extended that ability to the most advanced memory and storage technology. Today, those technologies require extensive application re-architectures to realize improvements. With Pliops, customers can enjoy the full performance and efficiency benefits of SCM and QLC SSDs with today’s mainstream applications like MySQL, Cassandra and Redis. We are pleased that FMS has taken notice and awarded us this honor.”

About Pliops

Founded in 2017, Pliops is a technology innovator focused on making data centers run faster and more efficiently. Its technology addresses skyrocketing data volumes and solves the slowing compute performance problem. The company’s Storage Processor is built upon a groundbreaking patent-pending approach that accelerates storage functions. Focused on creating the next wave of the accelerated data center, the Pliops Storage Processor enables cloud and enterprise customers to access data up to 100 times faster – using just a fraction of the computational load and power consumption. With Pliops technology, databases, analytics and other data-intensive applications are able to reach their full potential. Investors include Softbank Ventures Asia, Intel Capital, Western Digital, NVIDIA, and Xilinx.

For more information visit www.pliops.com or connect on Twitter and LinkedIn.

Media Contact:

Stephanie Olsen
Lages & Associates
(949) 453-8080
[email protected]

NEWTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — 4D Path, a company conceived by an experienced team of scientists, clinicians and management from leading research institutions including MIT, Harvard Medical School and the University of Cambridge, has unveiled a faster, more efficient approach to cancer diagnosis and biomarker profiling with better accuracy that accelerates and democratizes precision medicine for optimized patient care and clinical trials. The company, which has raised $6.4 million in funding to date, applies its cloud-based, quantitative approach to finding the data previously hidden in an H&E biopsy image without adding extra load to the current standard of care. As a result, the initial biopsy will no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step necessary without the need for additional molecular tests (e.g. immunohistochemistry, FISH, RNA-Seq, NGS).

Just from whole slide H&E biopsy/resection images, in seconds 4D Path can identify cancer type (in the pan cancer level), its prognostically significant subtypes, variants, grades, and molecular profile with overexpression status as well as benign lesions. Its accelerated and more accurate diagnostic tool is commercially available now for use in clinical trials to allow pharmaceutical and biopharmaceutical companies to efficiently focus more precisely on effective treatments and targeted therapies.

“Delayed and sometimes inaccurate cancer diagnosis is due largely to subjectivity, experience, variability in sampling and mood bias. Ancillary tests, designed to extract molecular profiles of the tumor and direct the right and effective treatment are lengthy, expensive and sometimes not accessible to the broad population (like in remote location),” said Rodrigo Navarro, president and CEO, 4D Path. “By eliminating the need for acquiring additional data, 4D Path’s patented methods and integrated platform accelerate complete, actionable and proven clinical insights that are completely objective. For both companion diagnostics and translational medicine, 4D Path can reduce the cost, time and complexity of clinical trials and patient management.”

Professor Andrew Hanby, specialist consultant breast histopathologist, NHS, UK, whose practice relies entirely on whole slide images (WSI) reporting, states: “Pathologists are an essential part of the patient care pathway in offering a gold standard diagnosis to which patients’ treatment is tailored. Unlike current rival AI methodologies, 4D Path’s technology significantly augments and revolutionizes the goal of achieving high levels of accuracy in diagnostics. It promises to enhance both the quality and efficacy of the process, giving patients the assurance that their treatment pathway has a solid and safe foundation. The value of this technology also extends beyond the complexity of clinical diagnostics in offering a robust analytical tool in environments where histopathologists are often lacking, such as clinical trials and grass roots cancer research.”  

“4D Path applies statistical physics, cancer cell biology and mathematical principles to extract hidden dynamics encoded in a static tissue image to identify tumor-specific phenotypic and genotypic fingerprints. The patented algorithm relies on causation instead of merely statistical correlation to compute digital biomarkers and output the decisions. As a result, unlike emerging AI technologies, 4D Path’s platform does not involve any kind of training of the histopathology images to learn to recognize diagnostic entities, nor does it require any pre-annotation or any other human intervention (like selecting handcrafted features) to direct the algorithm to regions of interest,” said Tathagata Dasgupta, founder & CKO/CTO, 4D Path. “By using previously unseen data unveiled by the proven diagnostic platform, 4D Path is the first biomedical endeavor of its kind to transition from R&D to validation in real-life clinical settings.”

Founded in 2016 and previously in stealth mode, the company has achieved significant milestones including the approval of its first utility patent application earlier this year. The company operates a robust IT infrastructure and is expanding its platform compatibilities and ways to integrate it with existing PACS (Picture Archiving and Communication System). It has also extended its ability to analyze H&E stained biopsy and resection images to cytology images with standard stains (H&E or Papanicolaou) and is digital slide scanner agnostic.

4D Path Boilerplate

Just because you cannot see something, does not mean it is not there. 4D Path’s patented precision oncology platform unveils previously hidden data to instantly provide biomarker profiling and stratification directly from H&E Whole Slide biopsy/resection images only. 4D Path’s cloud-based, quantitative approach eliminates the need for additional molecular tests (e.g., immunohistochemistry, FISH, RNA-Seq, NGS), accelerating complete, actionable and objective insight leading to expedited and democratized precision medicine for optimized patient care and clinical trials. Visit www.4dpath.com to learn more. 

PR Contact 
Jordan Bouclin
SVM PR & Marketing Communications
[email protected]
(401)490-9700

MONTREAL, Nov. 12, 2020 (GLOBE NEWSWIRE) — Yvan Allaire, Chair of the Board of the Institute for Governance (IGOPP), is pleased to announce the appointment of Louis Audet and Isabelle Marcoux, respectively Executive Chair of the Board of Cogeco Inc. and Chair of the Board of Transcontinental Inc., to the IGOPP’s Board.

Mr. Allaire emphasized Mr. Audet and Ms. Marcoux’s entrepreneurial background and their extensive experience as directors of publicly traded companies and NPOs. He was pleased that they have agreed to join the IGOPP’s Board: “These two new directors bring their expertise to our Board, which is made up of people with a wide range of experience in governance of public and private-sector organizations.”

About Mr.
Audet’s
career
:

http://corpo.cogeco.com/cgo/en/governance/board-directors/

About Ms.
Marcoux
’s career
:

https://tctranscontinental.com/en-us/about-us/governance/board-directors-and-committees/isabelle-marcoux-cm

About I
GOPP

Created in 2005 by two academic institutions (HEC Montréal and Concordia University – The John Molson School of Business), the Stephen Jarislowsky Foundation and the Autorité des marchés financiers, the Institute for governance (IGOPP) has become a centre for excellence about governance of public and private organizations. Through research and publications, seminars on value-creating governance®, policy papers and board evaluation and governance interventions, IGOPP has become a key reference on all issues of governance in the private and public sectors.

For more information:

Majida Lamnini
,
MBA ( C)

Director of Strategic Initiatives | IGOPP | 514-439-9301| [email protected]

 

Aurora, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) — BERNINA of America, the premier manufacturer of sewing, embroidery and quilting machines, is pleased to announce that The Quilter’s Trunk, a BERNINA Dealer located in Chicago, Ill., was named a winner of the 2020 Synchrony Pillars Project. The Synchrony Pillars Project celebrates small businesses that have made a significant difference in their communities.

As one of twenty businesses selected, The Quilters Trunk was rewarded with $10,000 to grow its business and to honor their resiliency and ability to transform the lives of those in their community. This year’s criteria focused on how businesses adapted to the pandemic to make their community stronger and their commitment to diversity and inclusion. In 2020, The Quilter’s Trunk partnered with their local Alderman’s office to give away fabric kits for over 6,000 masks. The store also served as a collection point for masks that were distributed to healthcare workers, nursing home residents and other high-risk individuals. They also continued to champion diversity and inclusion efforts by supporting several local organizations and ensuring all customers are given the same high level of service and respect. The Quilter’s Trunk is the only sewing machine retailer to be amongst the 20 winning businesses.

“We are honored and humbled to be a winner of the 2020 Synchrony Pillars Project,” said Katie Nathwani, Owner of The Quilter’s Trunk. “2020 has presented many unique challenges that have given us the opportunity to connect with and serve our community in new and exciting ways. We share this honor with our passionate and dedicated customers who continue to support us.”

The Quilter’s Trunk is an authorized BERNINA Dealer that provides top-quality service to area residents. The Dealer offers BERNINA sewing machines, software, accessories and a variety of sewing, embroidery and quality classes for people of all skill levels.

To learn more about The Quilter’s Trunk please visit thequilterstrunk.com or their Facebook page.

To learn more about BERNINA please visit bernina.com.

###

About BERNINA

Founded in Switzerland more than 100 years ago, BERNINA is the world’s premier manufacturer with a proven reputation for offering quality state-of-the-art sewing, quilting and embroidery machines, overlockers, and embroidery software. BERNINA’s leadership is marked by an impressive number of ambassadors, industry leaders, influencers and bloggers who chose to partner with the company. BERNINA products are sold in the United States through a network of over 400 fully trained independent dealerships that also offer support and education. Select BERNINA and bernette machines, and BERNINA software can also be purchased online. BERNINA products are designed for beginning to advanced sewists and priced to meet a variety of budgets, with new products being introduced every year. You can follow BERNINA on Facebook, Instagram, Pinterest and read BERNINA’s WeAllSew blog. To learn more about BERNINA and to find a Dealer, visit www.bernina.com.

Attachment

• 123334285_2813215398957557_7728039094368622100_o

Tyler Rabel
Two by Four
312-445-4728
[email protected]